Brian McNulty - 26 Sep 2023 Form 3 Insider Report for MIRA PHARMACEUTICALS, INC. (MIRA)

Role: 10%+ Owner
Signature: /s/ Michelle Yanez, Attorney-in-Fact for Brian McNulty
Issuer symbol: MIRA
Transactions as of: 26 Sep 2023
Transactions value $: $0
Form type: 3
Filing time: 12 Oct 2023, 16:26:45 UTC
Next filing: 27 Dec 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MIRA	Common Stock						10K	26 Sep 2023	Direct	F1
holding	MIRA	Common Stock						2.86M	26 Sep 2023	By Trust	F2
holding	MIRA	Common Stock						660K	26 Sep 2023	By Trust	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	MIRA	Common Stock (right to buy)							26 Sep 2023	Common Stock	1M	$5.00	By Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are owned directly by Brian McNulty ("Mr. McNulty").
F2	These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities.
F3	These securities are owned directly by a trust and indirectly by Mr. McNulty as trustee of such trust. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities.